Table 2 Univariate analysis with respect to 5-year survival of the patients with non-small cell lung cancer
From: Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer
Clinical features | Patients | 5-year survival (%) | P Valueb | |
|---|---|---|---|---|
Patients | Rate (%) | |||
72 | 29 | 40.3 | ||
Gender | 0.352 | |||
Male | 40 | 15 | 37.5 | |
Female | 32 | 14 | 43.8 | |
Age, year | 0.624 | |||
< 60 | 31 | 12 | 38.7 | |
≥ 60 | 41 | 17 | 41.5 | |
Smoking | 0.182 | |||
No | 48 | 22 | 45.8 | |
Yes | 24 | 7 | 29.2 | |
Histological type | 0.115 | |||
SCC | 32 | 9 | 28.1 | |
ADC | 40 | 20 | 50.0 | |
Differentiation | 0.035 | |||
Well | 13 | 6 | 46.2 | |
Moderately | 44 | 20 | 45.5 | |
Poorly | 15 | 3 | 20.0 | |
pT | 0.069 | |||
pT1 | 11 | 8 | 72.7 | |
pT2 | 51 | 20 | 39.2 | |
pT3 | 10 | 1 | 10.0 | |
pN | 0.001 | |||
− | 24 | 19 | 79.2 | |
+ | 48 | 10 | 20.8 | |
pTNM | 0.001 | |||
pI | 15 | 15 | 100.0 | |
pII | 42 | 13 | 31.0 | |
pIIIa | 15 | 1 | 6.7 | |
Chemotherapy | 0.893 | |||
No | 10 | 4 | 40.0 | |
Yes | 62 | 25 | 40.3 | |
Radiotherapy | 0.801 | |||
No | 45 | 18 | 40.0 | |
Yes | 27 | 11 | 40.7 | |
EGFR-TKI therapy | 0.788 | |||
No | 40 | 17 | 42.5 | |
Yes | 32 | 12 | 37.5 | |
KIF21B | 0.001 | |||
Low | 28 | 18 | 64.3 | |
High | 44 | 11 | 25.0 | |